Skip to content
Instagram Facebook-f Twitter Youtube
  • About
  • Blog
  • Issues
    • Antitrust
    • Congress
    • Defense
    • Earmarks
    • Energy
    • Federal Agencies
    • Harm Reduction
    • Healthcare
    • Intellectual Property
    • International Issues
    • Postal Reform
    • Regulation
    • Spending
    • State Issues
    • Taxes
    • Technology
    • Telecommunications
  • Newsroom
  • Publications
  • Contribute
  • Consumer Center
  • About
  • Blog
  • Issues
    • Antitrust
    • Congress
    • Defense
    • Earmarks
    • Energy
    • Federal Agencies
    • Harm Reduction
    • Healthcare
    • Intellectual Property
    • International Issues
    • Postal Reform
    • Regulation
    • Spending
    • State Issues
    • Taxes
    • Technology
    • Telecommunications
  • Newsroom
  • Publications
  • Contribute
  • Consumer Center

Menu

Blog

Issues

  • Congress
  • Defense
  • Earmarks
  • Energy
  • Federal Agencies
  • Healthcare
  • Harm Reduction
  • Intellectual Property
  • International Issues
  • Postal Reform
  • Regulation
  • Spending
  • State Issues
  • Taxes
  • Telecommunications
  • Technology
  • Congress
  • Defense
  • Earmarks
  • Energy
  • Federal Agencies
  • Healthcare
  • Harm Reduction
  • Intellectual Property
  • International Issues
  • Postal Reform
  • Regulation
  • Spending
  • State Issues
  • Taxes
  • Telecommunications
  • Technology

Category: Federal Agencies

Op-Ed: Alzheimer’s Drug Approval a Big Leap Forward for FDA

Read More »
January 25, 2023 No Comments

Op-Ed: FDA’s Campaign Against Misinformation Should Start With Its Own

Read More »
January 18, 2023 No Comments

The CDC’s Peddling of Misinformation About Vaping is a Threat to Public Health

Read More »
January 5, 2023 No Comments

How Lina Khan [Almost] Stole Christmas

Read More »
December 22, 2022 No Comments

Op-Ed: Playing Games at the FTC

Read More »
December 16, 2022 No Comments

Why the Most Expensive Medication Ever Is Actually a Great Deal

Read More »
December 12, 2022 No Comments

Three Takeaways from New FDA Report

Read More »
December 9, 2022 No Comments

Mission Creep at the SEC

Read More »
December 7, 2022 No Comments

TPA Submits Comments to FTC on Commercial Surveillance and Data Security

Read More »
November 2, 2022 No Comments

Republican House Members Demand Probe of HUD Spending in the U.S. Virgin Islands

Read More »
October 31, 2022 No Comments
Page1 … Page11 Page12 Page13 Page14 Page15 … Page39

Copyright © 2026 Taxpayers Protection Alliance

1101 14th Street NW, Suite 500 Washington, D.C. 20005

Privacy Policy           Press Inquiries